Dr. Mo Amin is the Vice President of Value, Access & Policy at AstraZeneca Canada Inc., one of Canada’s leading biopharmaceutical companies. Mo brings to the position more than 27 years of experience in the biopharmaceutical industry, including extensive experience within the areas of Market Access, Medical Affairs, Health Economics and Real World Evidence (RWE). In his current role, he leads AstraZeneca’s Access organization that includes HTA, strategic pricing, public and private negotiations, payer engagement, strategic partnerships and patient support programs and data analytics.
His career spans roles in academia and both the private and public sector. Among some of the positions Mo has held include Adjunct Professor, Department of Medicine – University of Ottawa; Scientific Advisor – Common Drug Review (CDR) and Canadian Agency for Drugs and Technologies in Health (CADTH); Director of Health Economics, Pricing & Reimbursement with Bristol-Myers Squibb in Canada and the U.S.; and Regional Head for Global Health Economics, Epidemiology & RWE – Intercontinental Region, Amgen.
Prior to joining AstraZeneca, Mo was Regional Head of Global Medical Affairs at Sanofi, leading medical, access and evidence generation strategies for Asia-Pacific, Africa, Middle East and China regions.
Mo is a trained medical doctor with a Master’s in Economics from the University of Essex and a PhD in Health Economics and Policy from the University of London in the UK.
All Sessions by Mo AminPrinter Friendly See Full Agenda
Agenda: Day 1 Oct 5, 2020
Agenda: Day 2 Oct 6, 2020